These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 5737592

  • 1. [Differences in the effect of secretin in normal weight and obesity].
    Raptis S, Schröder KE, Telib M, Pfeiffer EF.
    Wien Z Inn Med; 1968; 49(11):423-9. PubMed ID: 5737592
    [No Abstract] [Full Text] [Related]

  • 2. [Stimulation of insulin secretion in diabetics using secretin].
    Raptis S, Schröder KE, Faulhaber JD, Pfeiffer EF.
    Dtsch Med Wochenschr; 1968 Dec 13; 93(50):2420-4. PubMed ID: 5698974
    [No Abstract] [Full Text] [Related]

  • 3. Effects of secretin on insulin secretion and glucose tolerance.
    Dupré J, Chisholm DJ, McDonald TJ, Rabinovitch A.
    Can J Physiol Pharmacol; 1975 Dec 13; 53(6):1115-21. PubMed ID: 1222379
    [Abstract] [Full Text] [Related]

  • 4. The role of the exocrine pancreas in the stimulation of insulin secretion by intestinal hormones. 3. Insulin responses to secretin and pancreozymin, and to oral and intravenous glucose, in patients suffering from chronic insufficiency of the exocrine pancreas.
    Raptis S, Rau RM, Schröder KE, Hartmann W, Faulhaber JD, Clodi PH, Pfeiffer EF.
    Diabetologia; 1971 Jun 13; 7(3):160-7. PubMed ID: 5560917
    [No Abstract] [Full Text] [Related]

  • 5. [Antagonistic action of intestinal hormones and diazoxide on insulin secretion in humans].
    Raptis S, Schröder KE, Faulhaber JD, Pfeiffer EF.
    Horm Metab Res; 1969 May 13; 1(3):116-21. PubMed ID: 4946718
    [No Abstract] [Full Text] [Related]

  • 6. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
    Bigelow-Sherman JD, Shima K, Borden EK, Foà PP, Penhallegon R.
    Acta Diabetol Lat; 1970 May 13; 7(1):68-92. PubMed ID: 5493440
    [No Abstract] [Full Text] [Related]

  • 7. Insulin release in response to oral glucose in obesity: the effect of reduction of body weight.
    Farrant PC, Neville RW, Stewar GA.
    Diabetologia; 1969 Jun 13; 5(3):198-200. PubMed ID: 5373821
    [No Abstract] [Full Text] [Related]

  • 8. Role of insulin and glucagon in obesity.
    Schade DS, Eaton RP.
    Diabetes; 1974 Aug 13; 23(8):657-61. PubMed ID: 4854163
    [No Abstract] [Full Text] [Related]

  • 9. Insulin secretion following administration of secretin in patients with diabetes mellitus.
    Deckert T.
    Acta Endocrinol (Copenh); 1968 Sep 13; 59(1):150-8. PubMed ID: 4884927
    [No Abstract] [Full Text] [Related]

  • 10. [On the release of insulin in patients with fatty liver].
    Waldhäusl W, Irsigler K.
    Wien Klin Wochenschr; 1969 Jul 18; 81(29):544-6. PubMed ID: 5801626
    [No Abstract] [Full Text] [Related]

  • 11. Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia.
    Bagdade JD, Bierman EL, Porte D.
    Diabetes; 1971 Oct 18; 20(10):664-72. PubMed ID: 5110698
    [No Abstract] [Full Text] [Related]

  • 12. Effect of age on corbohydrate metabolism.
    O'Sullivan JB, Mahan CM, Freedlender AE, Williams RF.
    J Clin Endocrinol Metab; 1971 Oct 18; 33(4):619-23. PubMed ID: 4937464
    [No Abstract] [Full Text] [Related]

  • 13. [Stimulation of insulin secretion and hypoglycemia by medium chain triglyceride].
    Ide H.
    Nihon Naika Gakkai Zasshi; 1971 Feb 18; 60(2):115-24. PubMed ID: 5103075
    [No Abstract] [Full Text] [Related]

  • 14. Effect of the gastrointestinal hormones, secretin and cholecystokinin-pancreozymin, on insulin and glucagon release in healthy and diabetic subjects.
    Raptis S, Schröder KE, Rothenbuchner G, Pfeiffer EF.
    Isr J Med Sci; 1972 Jun 18; 8(6):769. PubMed ID: 4559420
    [No Abstract] [Full Text] [Related]

  • 15. Stimulation of insulin secretion by glucagon and secretin.
    Deckert T.
    Acta Endocrinol (Copenh); 1968 Apr 18; 57(4):578-84. PubMed ID: 5695271
    [No Abstract] [Full Text] [Related]

  • 16. [Course of immunoreactive insulin, glycemia and fatty acid levels after stimulation with glucose and aminophylline].
    Bartos V, Maláková B, Spĕváková A, Vísek V, Krombholzová L, Musil J, Kimlová I, Prokopec J.
    Vnitr Lek; 1975 Mar 18; 21(3):261-8. PubMed ID: 1119105
    [No Abstract] [Full Text] [Related]

  • 17. "Staircase" glucose stimulation of insulin secretion in obesity. Measure of beta-cell sensitivity and capacity.
    Karam JH, Grodsky GM, Ching KN, Schmid F, Burrill K, Forsham PH.
    Diabetes; 1974 Sep 18; 23(9):763-70. PubMed ID: 4855479
    [No Abstract] [Full Text] [Related]

  • 18. Differences in insulin, growth hormone and pancreatic enzyme secretion after intravenous and intraduodenal administration of mixed amino acids in man.
    Raptis S, Dollinger HC, Schröder KE, Schleyer M, Rothenbuchner G, Pfeiffer EF.
    N Engl J Med; 1973 Jun 07; 288(23):1199-202. PubMed ID: 4700552
    [No Abstract] [Full Text] [Related]

  • 19. Short-term hormonal responses to oral glucose in normal and abnormal energy metabolism.
    Baird JD.
    Proc Nutr Soc; 1971 May 07; 30(1):26-36. PubMed ID: 5090477
    [No Abstract] [Full Text] [Related]

  • 20. Improvement in glucose tolerance of fasting obese patients given oral potassium.
    Anderson JW, Herman RH, Newcomer KL.
    Am J Clin Nutr; 1969 Dec 07; 22(12):1589-96. PubMed ID: 5362486
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.